Form 4: Guardant Health CPO Sells Shares After Option Exercise

Guardant Health's Chief People Officer, Terilyn J. Monroe, exercised stock options and subsequently sold a portion of the acquired shares under a pre-arranged 10b5-1 plan.

Summary

• Terilyn J. Monroe, Chief People Officer of Guardant Health, Inc. (GH), engaged in a series of transactions on December 1, 2025.
• Monroe exercised stock options to acquire 35,000 shares of common stock at an exercise price of $20.14 per share.
• An additional 15,000 shares of common stock were acquired through option exercise at a price of $28.61 per share.
• A total of 55,167 shares of common stock were subsequently sold at weighted average prices ranging from $105.33 to $107.85.
• These transactions were conducted pursuant to a Rule 10b5-1(c) plan, indicating they were pre-scheduled.
• Following these reported transactions, Monroe directly holds 20,920 shares of Guardant Health common stock.
• Monroe also beneficially owns 43,204 and 32,627 derivative securities (stock options) after the reported exercises.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transactions are routine insider activity under a pre-arranged 10b5-1 plan, involving option exercise and subsequent share sales for liquidity or tax purposes, rather than a signal of changing company fundamentals.

Positives

• The executive realized significant gains by exercising stock options at lower prices ($20.14 and $28.61) and selling shares at substantially higher market prices (ranging from $105.33 to $107.85).
• The transactions were executed under a Rule 10b5-1(c) plan, which suggests pre-planned activity for liquidity or tax management rather than a reaction to immediate company-specific news.

Negatives

• The sale of 55,167 shares by a key executive, even under a 10b5-1 plan, could be interpreted by some investors as a slight reduction in insider confidence, although it is a common practice for personal financial planning.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Terilyn J. Monroe, Chief People Officer, engaged in the exercise of stock options and subsequent sale of common stock, which are considered related party transactions as they involve an executive of the company.

Stakeholder Impact

• Shareholders: May view the insider selling as a neutral event due to the 10b5-1 plan, or as a slight negative if interpreted as reduced confidence, though the gains realized are substantial.
• Employees: The Chief People Officer's compensation realization could be seen as a positive example of executive reward, potentially impacting morale.
• Management: These are standard executive compensation and liquidity management activities.

Key Dates

Recommendation

The filing details routine insider transactions under a pre-arranged 10b5-1 plan, involving the exercise of stock options and subsequent sale of shares for liquidity or tax purposes. These transactions do not provide new fundamental insights into Guardant Health's operational performance or strategic direction. Therefore, the filing itself does not warrant a change in investment recommendation; a 'hold' stance is maintained pending further fundamental analysis.

Keywords

Guardant Health, GH, Insider Trading, Form 4, Stock Options, Executive Compensation, Terilyn J. Monroe, Chief People Officer, 10b5-1 Plan, Share Sale